Influence of CYP2C19 Polymorphism on PK/PD of Omeprazole

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

December 31, 2014

Conditions

Stomach Ulcer

Interventions

DRUG

Omeprazole

Trial Locations (1)

Seoul National University Hospital, Seoul

All Listed Sponsors

lead

Seoul National University Hospital

OTHER

NCT02299687 - Influence of CYP2C19 Polymorphism on PK/PD of Omeprazole | Biotech Hunter | Biotech Hunter